These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8771558)
41. Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man. Ullman B; Franco-Cereceda A; Hulting J; Lundberg JM; Sollevi A J Intern Med; 1990 Dec; 228(6):583-9. PubMed ID: 2280235 [TBL] [Abstract][Full Text] [Related]
42. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs. Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239 [TBL] [Abstract][Full Text] [Related]
44. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo. Malmström RE; Lundberg JN; Weitzberg E Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028 [TBL] [Abstract][Full Text] [Related]
45. Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated. Zukowska-Grojec Z; Shen GH; Capraro PA; Vaz CA Physiol Behav; 1991 Apr; 49(4):771-7. PubMed ID: 1881983 [TBL] [Abstract][Full Text] [Related]
46. Plasma neuropeptide Y levels in the acute and early convalescent phase after myocardial infarction. Omland T; Opstad K; Dickstein K Am Heart J; 1994 Apr; 127(4 Pt 1):774-9. PubMed ID: 8154414 [TBL] [Abstract][Full Text] [Related]
47. Hemodynamic and plasma catecholamine responses to hyperthermic cancer therapy in humans. Kim YD; Lake CR; Lees DE; Schuette WH; Bull JM; Weise V; Kopin IJ Am J Physiol; 1979 Nov; 237(5):H570-4. PubMed ID: 495763 [TBL] [Abstract][Full Text] [Related]
48. Modulation of vascular function by neuropeptide Y during development of hypertension in spontaneously hypertensive rats. Zukowska-Grojec Z; Golczynska M; Shen GH; Torres-Duarte A; Haass M; Wahlestedt C; Myers AK Pediatr Nephrol; 1993 Dec; 7(6):845-52. PubMed ID: 7907499 [TBL] [Abstract][Full Text] [Related]
49. Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension. Wocial B; Ignatowska-Switalska H; Pruszczyk P; Zukowska-Grójec Z; Januszewicz W Mater Med Pol; 1994; 26(4):127-31. PubMed ID: 7666676 [TBL] [Abstract][Full Text] [Related]
50. Hemodynamic and pulmonary changes during open, carbon dioxide pneumoperitoneum and abdominal wall-lifting cholecystectomy. A prospective, randomized study. Galizia G; Prizio G; Lieto E; Castellano P; Pelosio L; Imperatore V; Ferrara A; Pignatelli C Surg Endosc; 2001 May; 15(5):477-83. PubMed ID: 11353965 [TBL] [Abstract][Full Text] [Related]
51. Plasma neuropeptide Y concentration is increased after hemorrhage in conscious rats: relative contributions of sympathetic nerves and the adrenal medulla. Morris M; Kapoor V; Chalmers J J Cardiovasc Pharmacol; 1987 May; 9(5):541-5. PubMed ID: 2439834 [TBL] [Abstract][Full Text] [Related]
52. Plasma catecholamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis. Braillon A; Gaudin C; Poo JL; Moreau R; Debaene B; Lebrec D Hepatology; 1992 Jan; 15(1):58-62. PubMed ID: 1727800 [TBL] [Abstract][Full Text] [Related]
53. Plasma neuropeptide Y and catecholamines in women and men with essential hypertension. Wocial B; Ignatowska-Switalska H; Pruszczyk P; Jedrusik P; Januszewicz A; Lapinski M; Januszewicz W; Zukowska-Grojec Z Blood Press; 1995 May; 4(3):143-7. PubMed ID: 7670647 [TBL] [Abstract][Full Text] [Related]
54. Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. Feng QP; Hedner T; Andersson B; Lundberg JM; Waagstein F Br Heart J; 1994 Mar; 71(3):261-7. PubMed ID: 8142196 [TBL] [Abstract][Full Text] [Related]
55. Influence of sodium intake on circulating levels of neuropeptide Y. Waeber B; Corder R; Aubert JF; Nussberger J; Gaillard R; Brunner HR Life Sci; 1987 Sep; 41(11):1391-6. PubMed ID: 3626763 [TBL] [Abstract][Full Text] [Related]
56. Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines. Castagné V; Corder R; Gaillard R; Mormède P Regul Pept; 1987 Oct; 19(1-2):55-63. PubMed ID: 3317527 [TBL] [Abstract][Full Text] [Related]
57. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226. Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522 [TBL] [Abstract][Full Text] [Related]
58. Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder. Oades RD; Daniels R; Rascher W Psychiatry Res; 1998 Aug; 80(2):177-86. PubMed ID: 9754697 [TBL] [Abstract][Full Text] [Related]
59. Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. Hulting J; Sollevi A; Ullman B; Franco-Cereceda A; Lundberg JM Cardiovasc Res; 1990 Feb; 24(2):102-8. PubMed ID: 2328516 [TBL] [Abstract][Full Text] [Related]
60. The relationship of plasma neuropeptide Y levels with coronary collateral development. Bas HD; Baser K; Yilmaz S; Tuncel AF; Yaman B; Abaci A Coron Artery Dis; 2014 Jan; 25(1):73-8. PubMed ID: 24077326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]